Table TDI-5 part (ii). Characteristics of all clients entering treatment: demographics and primary drug at treatment in 2003 or most recent year available. Primary drug type used by clients (percentage of all clients) and of those, the percentage injecting it

Country

 

Opiates

% inj

Cocaine

% inj

Amphetamines

% inj

Ecstasy

Hallucinogens

% inj

Cannabis

Others

Belgium

(1)

33.2

37.7

6.0

11.0

12.0

6.0

1.0

0.0

0.0

15.0

32.8

Czech Republic

 

25.1

87.7

0.3

4.5

52.9

84.4

0.6

0.3

3.4

16.5

4.3

Denmark

 

50.4

46.1

4.4

15.2

5.8

3.3

1.2

0.0

 

25.6

12.6

Germany

(2)

55.0

68.0

7.0

 

6.0

3.1

 

0.0

 

26.0

6.0

Greece

 

88.8

51.9

1.5

15.1

0.0

 

0.4

0.1

0.0

7.4

1.8

Spain

(3)

59.0

24.0

26.0

9.0

1.0

9.0

1.0

0.1

14.0

11.0

1.9

France

(4)

70.6

 

5.8

 

0.3

 

1.1

0.3

 

17.6

4.3

Ireland

(5)

64.1

56.1

1.7

6.3

0.4

11.8

6.0

0.2

0.0

24.1

3.5

Italy

 

76.3

66.9

8.9

14.9

0.2

1.9

0.8

0.1

 

10.3

3.4

Cyprus

 

67.2

83.1

9.0

0.0

0.4

0.0

3.4

0.0

 

17.7

2.3

Latvia

 

52.6

83.9

0.8

25.0

12.0

63.9

1.4

1.8

0.0

3.3

29.9

Lithuania

 

78.8

 

0.1

 

2.5

 

 

0.2

0.5

 

18.4

Luxembourg

 

76.0

64.0

11.0

45.0

0.0

 

0.0

0.0

 

8.0

5.0

Hungary

 

17.1

65.2

0.9

6.1

3.0

25.4

2.1

0.6

2.4

25.2

51.1

Malta

(6)

77.6

77.7

6.9

15.6

0.0

 

0.8

0.2

0.0

14.3

0.2

Netherlands

 

35.0

12.0

38.0

2.0

3.0

1.0

1.0

1.0

0.0

20.0

2.0

Austria

(7)

100.0

100.0

0.0

0.0

0.0

0.0

0.0

0.0

0.0

0.0

0.0

Poland

(8)

30.3

 

0.8

 

8.1

 

 

0.5

 

3.3

57.0

Portugal

(9)

 

 

 

 

 

 

 

 

 

 

 

Slovenia

(10)

88.0

99.7

0.8

0.3

0.3

 

0.2

0.0

 

10.4

0.3

Slovakia

 

51.8

80.9

0.8

25.0

17.2

37.9

0.5

0.5

9.1

14.0

15.2

Finland

 

36.5

86.0

0.2

 

32.8

79.8

0.5

0.2

 

20.8

9.0

Sweden

 

32.8

68.2

1.0

5.9

36.9

62.6

0.8

0.1

0.0

18.5

9.9

United Kingdom

(11)

72.0

49.0

9.0

6.0

3.0

29.0

1.0

0.1

7.0

10.0

4.9

Bulgaria

 

95.6

79.1

0.5

0.0

0.5

0.0

0.0

0.0

 

2.0

1.4

Romania

 

68.0

 

1.0

 

0.0

 

0.0

0.0

 

2.0

29.0

Notes: 

Data are not available for: Estonia, Norway, Turkey 

Injecting as a route of administration is not reported for cannabis 

(1) Last data available refer to 1999. 

(2) Data on percentage of clients injecting opiates only include heroin; data on injection are calculated on the total number of clients regardless the primary substance used. 

(3) Last data available refer to 2002. 

(4) Data on treatment demand referred to the annual census on clients in treatment carried out in November 2003. 

(5) Last data available refer to 2002. 

(6) Data on all clients refer to 9 treatment centres, for which data were available in 2003: 3 outpatient treatment centres, 3 inpatient treatment centres and 3 treatment units in prison 

(7) Data refer to clients in substitution treatment only; figures for opiates as main drug and injecting use are consequently 100%. 

(8) Last data available refer to 2002. 

(9) Only total number of clients is available for all treatments. 

(10) Data refer only to outpatient treatment centres. 

(11) Data relate to the period from 1 April 2002 to 31 March 2003 for Scotland and Northern Ireland; for England from April 2003 to March 2004; Wales: six months periods ending 30 September 2001 and 31 March 2002 combined. 

Sources:

2004 Reitox national reports - standard table 3

See [Table TDI-1] for details on sources. 

Data filter | tditab05b-en.xml